What are you looking for today?

Haggag, Yusuf. A, Matchett, Kyle B., Dakirc, El-Habib, Buchanan, Paul, Osman, Mohammed A., Elgizawyb, Sanaa A., El-Tanani, Mohamed, Faheem, Ahmed and McCarron, Paul A. (2017) Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells. International Journal of Pharmaceutics, 521 (1-2). pp. 40-53. ISSN 0378-5173

Document

  • [thumbnail of Peptide_manuscript.pdf]
    Peptide_manuscript.pdf - Accepted Version

Abstract

Abstract

Ran is a small ras-related GTPase and is highly expressed in aggressive breast carcinoma. Overexpression induces malignant transformation and drives metastatic growth. We have designed a novel series of anti-Ran-GTPase peptides, which prevents Ran hydrolysis and activation, and although they display effectiveness in silico, peptide activity is suboptimal in vitro due to reduced bioavailability and poor delivery. To overcome this drawback, we delivered an anti-Ran-GTPase peptide using encapsulation in PLGA-based nanoparticles (NP). Formulation variables within a double emulsion solvent evaporation technique were controlled to optimise physicochemical properties. NP were spherical and negatively charged with a mean diameter of 182–277 nm. Peptide integrity and stability were maintained after encapsulation and release kinetics followed a sustained profile. We were interested in the relationship between cellular uptake and poly(ethylene glycol) (PEG) in the NP matrix, with results showing enhanced in vitro uptake with increasing PEG content. Peptide-loaded, pegylated (10% PEG)-PLGA NP induced significant cytotoxic and apoptotic effects in MDA-MB-231 breast cancer cells, with no evidence of similar effects in cells pulsed with free peptide. Western blot analysis showed that encapsulated peptide interfered with the proposed signal transduction pathway of the Ran gene. Our novel blockade peptide prevented Ran activation by blockage of regulator of chromosome condensation 1 (RCC1) following peptide release directly in the cytoplasm once endocytosis of the peptide-loaded nanoparticle has occurred. RCC1 blockage was effective only when a nanoparticulate delivery approach was adopted.

Item Type: Article
Related URLs:
Depositing User: Callum Williams
URI: https://sure.sunderland.ac.uk/id/eprint/7191

Further Details

More Information

Identifiers

Item ID
7191
Identification Number
ISSN
0378-5173

Users with ORCIDS

Catalogue record

Date Deposited
28 Apr 2017 09:14
Last Modified
04 Jun 2025 17:28

Contributors

Author
Yusuf. A Haggag
Author
Kyle B. Matchett
Author
El-Habib Dakirc
Author
Paul Buchanan
Author
Mohammed A. Osman
Author
Sanaa A. Elgizawyb
Author
Mohamed El-Tanani
Author
Ahmed Faheem
Author
Paul A. McCarron

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year